This Master's degree in Cell and Gene Therapy provides an in-depth education in this cutting-edge and rapidly developing field. It is delivered by scientists and clinicians researching, developing and testing new treatments for genetically inherited and acquired diseases using gene delivery technology, stem cell manipulation and DNA repair techniques.
The degree covers all aspects of the subject, including basic biomedical science, molecular basis of disease, current and developing technologies and clinical applications. Students also receive vocational training in research methodology and statistics, how to perform a research project and complete a practical laboratory-based project.
Students undertake modules to the value of 180 credits.
The programme consists of four core modules (60 credits), four optional modules (60 credits) and a research dissertation (60 credits). A Postgraduate Diploma (120 credits, full-time nine months or flexible up to five years) is offered. A Postgraduate Certificate (60 credits, full-time 12 weeks, part-time nine months, or up to two years flexible) is offered.
Core modules -Molecular Aspects of Cell and Gene Therapy -Clinical Applications of Cell and Gene Therapy -Research Methodology and Statistics -Stem Cell and Tissue Repair
Research Methodology and Statistics is not a core module for the PG Certificate. Students of the PG Certificate can choose an optional module.
Optional modules -Foundations of Biomedical Sciences -Applied Genomics -HIV Frontiers from Research to Clinics -Molecular and Genetic Basis of Paediatric Disease -Understanding Research and Critical Appraisal: Biomedicine -Laboratory Methods in Biomedical Science -Research Methodology and Statistics
Dissertation/report All MSc students undertake an independent research project which culminates in a dissertation.
Teaching and learning Teaching includes lectures, seminars, problem classes and tutorials. Assessment varies depending on the module, but includes written coursework, multiple-choice questions, written examinations, a practical analysis examination and the dissertation.
The majority of our graduates have gone on to secure PhD places. Please see our programme website to read testimonials from past students which include their destinations following graduation.
Employability This novel programme aims to equip students for careers in research, education, medicine and business in academic, clinical and industrial settings. Examples of potential careers could include academic research and/or lecturing in a university or other higher education setting, conducting clinical trials as part of a team of clinicians, scientists and allied health professionals, monitoring and analysing the results of clinical trials as part of a clinical trials unit, developing new therapies or intellectual property in the pharmaceutical industry or other business ventures.
Why study this degree at UCL?
The Institute of Child Health (ICH), and its clinical partner Great Ormond Street Hospital (GOSH), is the largest centre in Europe devoted to clinical, basic research and post-graduate education in children's health, including haematopoietic stem cell transplantation (HSCT) and gene therapy.
The UCL School of Life & Medical Sciences (SLMS) has the largest concentration of clinicians and researchers active in cell and gene therapy research in Europe. This is reflected by the many groups conducting high-quality research and clinical trials in the field including researchers at the Institute of Child Health, the Division of Infection and Immunity, the Institute of Ophthalmology, the Institute for Women's Health, the Institute of Genetics and the Cancer Institute.
"I came across the field of gene therapy while I was studying for my BSc in Biotechnology back home at Universitat Autònoma de Barcelona (UAB). After one year of part-time research experience on gene therapy for a rare metabolic disease, I felt I could develop my professional career in this field and decided to make it the main theme of my postgraduate education. This is the reason why I applied to UCL for my MSc studies. The UK is one of the leading countries in gene therapy, and UCL in particular is a world-ranked university that gathers a great number of the country’s leading academics in this technology. As a matter of fact, it is the only university in the UK providing a postgraduate education focusing specifically on cell and gene therapy. It is very exciting to know that by studying at UCL I got the chance to learn and interact with leading experts in the field."
Applicants should be: a qualified medical practitioner, with a qualification equivalent to a UK MBBS; a non-clinical scientist with a minimum of an upper second-class BSc or equivalent in a life or biomedical science subject; or a healthcare, pharmaceutical or biotech professional and scientist with equivalent experience (minimum of three years).
17 May 2017
Recipient: University College London
Insert previous message below for editing?
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need. Why not add a message here